Prepping for ASCO? Investor Brad Loncar offers his own breakdown of what to watch for
Everybody has their own special lineup of the most keenly anticipated events scheduled for the upcoming session of ASCO this weekend. Brad Loncar, an independent investor who set up the Loncar Cancer Immunotherapy ETF $CNCR, has been prepping for this all year long.
Loncar wrote up a long list of things he’ll be watching for this upcoming weekend. I found it interesting and I think you will too. His list:
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.